iBio

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. It operates through the Biopharmaceuticals and Bioprocessing segments. The Biopharmaceuticals segment involves molecule discovery, development, and licensing activities. The Bioprocessing segment includes contract development and manufacturing services for recombinant proteins. The company was founded on April 17, 2008 and is headquartered in Bryan, TX.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q1 2025

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new frontiers against the most promising targets. The company was founded on April 17, 2008 and is headquartered in San Diego, CA.

IBio Inc (NYSE: IBIO) has added three anti-cancer targets to its pipeline of therapeutic candidates.  The Company seeks to change the drug development paradigm with the FastPharming Protein Expression System by reducing the time and cost to move from the initial concept to the clinic.

IBio Stock Ticks Higher After Adding Three Cancer Antibody Programs

BRYAN, Texas, July 08, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, has taken another major step towards leveraging the speed and throughput of its proprietary, plant-based FastPharming Protein Expression System® by announcing today it is adding three anti-cancer targets to its pipeline of therapeutic candidates. This development establishes the Company's new drug discovery capabilities announced just a few weeks ago.

iBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs

Barnwell Industries

Hut 8 Mining Corp

Ring Energy

Tonix Pharmaceuticals Hld

Ur-Energy

W&T Offshore

Trending penny stocks can be a great addition to your watchlist, here's 7 popular small-caps for your list The post Popular Penny Stocks to Buy Right Now? 7 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Popular Penny Stocks to Buy Right Now? 7 For Your Watchlist

Senmiao Technology

Diffusion Pharmaceuticals

Ault Global Holdings

Harmony Gold Mining Co Ltd

9 Meters Biopharma

Tellurian

Are these trending penny stocks worth adding to your watchlist? The post 7 Trending Penny Stocks That You Need to Know About in July 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

7 Trending Penny Stocks That You Need to Know About in July 2021

1847 GOEDEKER INC.

Jaguar Health

Ocean Power Technologies

T2 Biosystems

Best penny stocks to watch on Reddit with meme stocks on the rise? Check these 8 out The post 8 Reddit Penny Stocks to Watch With Meme Stocks on the Rise appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

8 Reddit Penny Stocks to Watch With Meme Stocks on the Rise

Enel Chile

9F Inc - ADR

Nxt-ID

SunLink Health Systems

These 7 penny stocks that you may not have heard of are selling below $3 per share and are worth significantly more than their present price. The post 7 Penny Stocks to Buy if You're Looking for Hidden Gems appeared first on InvestorPlace.

7 Penny Stocks to Buy if You're Looking for Hidden Gems

Axcella Health Inc

Tyme Technologies

Looking for biotech penny stocks to watch before Monday? Check these 3 out The post Best Biotech Penny Stocks to Buy?

Best Biotech Penny Stocks to Buy? 3 to Watch Before Monday

The stock price of iBio Inc (NYSEAMERICAN: IBIO) increased by over 18% during intraday trading. This is why it happened.

IBIO Stock Price: Over 18% Increase Explanation

BRYAN, Texas, June 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today the appointment of Evert (Eef) Schimmelpennink to its Board of Directors, effective immediately.

iBio Further Strengthens Board with Appointment of Veteran Biopharmaceutical Executive, Eef Schimmelpennink

Alpha Pro Tech

Gilead Sciences

Inovio Pharmaceuticals

Novavax

QuidelOrtho Corp

Sorrento Therapeutics Inc

The pandemic bolstered many stocks to buy. But with cases fading, this narrative is now questionable.

7 Former Pandemic Stocks to Buy That Are No Longer Running Hot

BRYAN, Texas, May 19, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that management will present an update on the Company's business at the UBS Global Healthcare Virtual Conference on Wednesday, May 26, 2021 at 4:00 p.m Eastern Time.

iBio to Present at the UBS Global Healthcare Virtual Conference

BRYAN, Texas., May 17, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its financial results for the fiscal quarter ended March 31, 2021.

iBio Reports Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update

Obalon Therapeutics

Precipio

Protagenic Therapeutics

These biotech penny stocks pushed up big today; but are they worth it? The post 4 Biotech Penny Stocks That You Need to Know About appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Biotech Penny Stocks That You Need to Know About

BRYAN, Texas, May 10, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it will report its fiscal 2021 third quarter financial results before market open on Monday, May 17, 2021. iBio management will host a webcast and conference call at 8:00 a.m. Eastern Time to discuss the results and provide a corporate update.

iBio to Report Fiscal 2021 Third Quarter Financial Results and Provide Corporate Update on Monday, May 17, 2021

Investors are excited about the company's new coronavirus vaccine program.

Here's Why iBio Stock Surged Friday

Ibio (IBIO) stock is soaring higher on Friday after announcing a next-generation vaccine program to treat the novel coronavirus. The post IBIO Stock: The Covid-19 Vaccine News Sending iBio Soaring Today appeared first on InvestorPlace.

IBIO Stock: The Covid-19 Vaccine News Sending iBio Soaring Today

iBio, Inc. (NYSE: IBIO) shares are trading higher after the company provided an update on its IBIO-201 program and reported on its progress in developing a second-generation subunit vaccine candidate, IBIO-202, being designed for the prevention of SARS-CoV-2 infection. "Combined with data from previous immune-response studies, these pathology results help demonstrate the potential value of LicKM as a useful tool in our vaccine development toolbox," said Tom Isett, Chairman and CEO of iBio.

Why Is iBio's Stock Trading Higher Today?

The stock price of iBio, Inc. (NYSEA:IBIO) increased by over 30% during at the opening of the stock market today. This is why it happened.

IBIO Stock: Over 30% Increase Intraday Explanation

iBio Inc (NYSE: IBIO) has provided an update on its IBIO-201 program and reported its progress in developing a second-generation subunit vaccine candidate, IBIO-202, being designed for the prevention of SARS-CoV-2 infection. IBIO-201 combines antigens derived from the spike protein ("S protein") fused with iBio's patented LicKM booster molecule

iBio Stock Is Trading Higher After Announcing Next-Gen COVID-19 Vaccine Candidate

BRYAN, Texas, May 06, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today provided an update on its IBIO-201 program and reported on its progress in developing a second-generation subunit vaccine candidate, IBIO-202, being designed for the prevention of SARS-CoV-2 infection.

iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program

A landmark legal settlement should bolster the biotech's growth prospects.

Why iBio Stock Soared Today

iBio Inc. (NYSE:IBIO) shares gapped higher Wednesday morning after the company announced it successfully resolved its lawsuit with Fraunhofer USA. The resolution confirms iBio's ownership of certain intellectual property related to plant-based biopharmaceutical production.

A Couple Key Levels To Watch In iBio's Stock

Cocrystal Pharma

Nemaura Medical

Nemaura Medical Inc. (NASDAQ: NMRD), iBio, Inc. (NYSE: IBIO) and Cocrystal Pharma, Inc. (NASDAQ: COCP) are among the healthcare movers Wednesday. Nemaura Rallies On Receipt of Orders: Nemaura, a medtech company developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announced the receipt of purchase orders for 5,000 sugarBEAT transmitters and 200,000 sugarBEAT sensors from its U.K. licensee DB Ethitronix.

Why Nemaura, iBio And Cocrystal Are Moving Wednesday

Ibio (IBIO) stock is on the rise Wednesday after announcing an end to its legal battle with Fraunhofer USA and settlement agreement. The post IBIO Stock: The Big Lawsuit News That Has iBio Shares Rocketing Today appeared first on InvestorPlace.

IBIO Stock: The Big Lawsuit News That Has iBio Shares Rocketing Today

The stock price of iBio Inc (NYSEAMERICAN: IBIO) increased from $1.29 to $1.68 (up 30.23%) pre-market. This is why it happened.

iBio Stock: From $1.29 To $1.68 (30.23% Increase) Pre-Market Explanation

News for iBio Stock (IBIO)